Pharmaceuticals company Trident Lifeline (BOM:543616) has completed the acquisition of an additional 50.49% of TLL Parenterals via the allotment of equity shares to make it a subsidiary, according to a Monday filing to the BSE.
In November, the company agreed to acquire 1,122,000 equity shares of 10 Indian rupees in the chemical and pharmaceutical manufacturer for a total price of 11.2 million rupees.
Price (INR): ₹291.75, Change: ₹+3.8, Percent Change: +1.30%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。